verified SJR 0,586 · Q2 • database Scopus / SJR & Web of Science indexed

Netherlands · SAGE Publications Ltd

workspace_premium Q2 — Medicine (miscellaneous) lock Subscription

Cancer Biomarkers

Cancer Biomarkers is a journal indexed in SJR in Medicine (miscellaneous) and Genetics with an H index of 57. It has an SJR impact factor of 0,586 and it has a best quartile of Q2. It has an SJR impact factor of 0,586.

ISSN: 1574-0153

Publisher: SAGE Publications Ltd

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,586 Q2

H-index 57

Acceptance rate pie_chart

31%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,586

H-index

Docs (year)

Docs 3y

348

Total refs

2475

Cites 3y

741

Citable 3y

345

Cites/Doc 2y

1.79

Ref/Doc

37.5

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Correlations of TNM staging and lymph node metastasis of gastric cancer with MRI features and VEGF expression

VEZT as a novel independent prognostic factor in gastric cancer

Emerging role of microRNA-21 in colorectal cancer

Elevated lactic acid is a negative prognostic factor in metastatic lung cancer

E74 like ETS transcription factor 3 (ELF3) is a negative regulator of epithelial- mesenchymal transition in bladder carcinoma

Downregulation of long noncoding RNA SNHG14 suppresses cell proliferation and invasion by regulating EZH2 in pancreatic ductal adenocarcinoma (PDAC)

DNMT3b -149C/T promoter variants and methylation of colorectal cancer-associated genes

DNA methylation and hydroxymethylation patterns in acute myeloid leukemia patients with mutations in DNMT3A and IDH1/2 and their combinations

Discovery and validation of ovarian cancer biomarkers utilizing high density antibody microarrays

Differential expression and clinical significance of serum protein among patients with clear-cell renal cell carcinoma

Differences in cysteine peptidases-like activity in sera of patients with breast cancer

Decreased expression of LncRNA MIR31HG in human bladder cancer

SHOW MORE ARTICLES

Cyst fluid iron-related compounds as useful markers to distinguish malignant transformation from benign endometriotic cysts

A case study on the identification of confounding factors for gene disease association analysis

Correlation of BRCA2 gene mutation and prognosis as well as variant genes in invasive urothelial carcinoma of the bladder

Clinical significance of the VEGF level in urinary bladder carcinoma

Circulating Epstein-Barr virus microRNA profile reveals novel biomarker for nasopharyngeal carcinoma diagnosis

Changed expression and function of P-gp in peripheral blood CD56 + cells predicting chemoresistance in non-Hodgkin lymphoma patients

Bioinformatics: Biomarkers of early detection

Bim may be a poor prognostic biomarker in breast cancer patients especially in those with luminal A tumors

Benign prostatic hyperplasia and prostate cancer differentiation via platelet to lymphocyte ratio

Analysis of T cell receptor repertoire based on Vbeta chain in patients with breast cancer

An increased level of MiR-222-3p is associated with TMP2 suppression, ERK activation and is associated with metastasis and a poor prognosis in renal clear cell carcinoma

An association of selected ERCC2 and ERCC5 genes polymorphisms, the level of oxidative DNA damage and its repair efficiency with a risk of colorectal cancer in Polish population

FAQs

Cancer Biomarkers has an SJR of 0,586 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Cancer Biomarkers is 31%.

Cancer Biomarkers

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Cancer Biomarkers?

What is the APC / publication cost?

What is the acceptance rate?